News & Updates

In patients with recurrent or metastatic inoperable head and neck squamous cell carcinoma (HNSCC), treatment with the novel antiangiogenic agent apatinib appears to be effective, leading to high rates of disease control, a recent study has found.

Failure of first-line antiretroviral therapy (ART) among kids is common, particularly young girls, according to a recent meta-analysis of studies from Ethiopia.

Dextromethorphan, when used in addition to standard analgesics, falls short of reducing the pain experienced by women undergoing medication abortion, according to a trial.

Intensifying the dose of ustekinumab to 4- or 6-weekly is a common recourse among Crohn’s disease (CD) patients, a recent study has found. Patients who had failed prior therapies are more likely to see such intensification.

In the treatment of adult patients with in-hospital cardiac arrest, lidocaine appears to result in more favourable survival and neurological outcomes as compared with amiodarone, a study has shown.

The combination of atezolizumab plus bevacizumab demonstrates promising antitumour activity in patients with advanced mucosal melanoma while having a manageable safety profile, according to the results of a phase II study.